Pinealon
A bioregulator peptide that may protect the brain and improve cognitive function by regulating pineal gland activity.
Common Dosage
10mg daily for 10-20 days
Category
Nootropic
- Improved focus
- Circadian rhythm support
- Neuroprotection
Pinealon is a tripeptide bioregulator (Glu-Asp-Arg) developed from the research of Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, following the same methodology that produced Epitalon. It is derived from pineal gland extract and is designed to target the brain and pineal gland specifically. Russian bioregulator therapy has been used clinically in Russia for decades, though it remains largely outside mainstream Western medicine.
Pinealon is proposed to act as a gene expression regulator — short peptides from Khavinson's research have demonstrated the ability to penetrate cell nuclei and interact with chromatin (DNA-protein complexes), potentially reactivating genes that become silenced with age. In brain tissue, Pinealon is studied for its effects on serotonin synthesis, antioxidant enzyme expression, and neuronal survival under hypoxic conditions.
- Age-related cognitive decline prevention
- Neuroprotection against hypoxic or ischemic injury
- Circadian rhythm support via pineal gland regulation
- Sleep quality improvement
- Antioxidant protection in neural tissue
- Depression and mood disorder research
Neuroprotection in Hypoxia Models
Animal studies have demonstrated that Pinealon reduces neuronal death in hypoxic conditions, with mechanisms including upregulation of antioxidant enzymes and maintenance of mitochondrial membrane potential — effects relevant to stroke, TBI, and altitude-related brain stress.
Age-Related Cognitive Support
Russian clinical research using Pinealon in elderly populations has reported improvements in cognitive test scores, memory retention, and mood stability over 10–20 day treatment courses — consistent with the compound's gene expression and neuroprotective mechanisms.
- Research base is predominantly Russian with limited independent Western replication
- Mechanism of gene expression modulation is powerful — potential for off-target gene regulation effects that are not yet characterized
- Long-term safety of repeated bioregulator courses has not been studied in rigorous controlled trials
- Oral bioavailability is uncertain — injectable or nasal routes are generally preferred for research protocols
- None reported commonly